| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT06184568 A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and… |
Trial completed |
| 2026-06-12 | NCT06184568 A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and… |
date change Completion moved earlier: 2026-06-30 -> 2026-02-09 |
| 2026-06-05 | NCT07559019 Safety and Preliminary Activity of BI115 in Advanced SCLC |
Recruitment opened |
| 2026-06-04 | NCT07483554 IBI343 in Combination Therapy for Advanced Malignant Solid Tumors |
Recruitment opened |
| 2026-06-03 | NCT07483567 IBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of… |
Recruitment opened |
| 2026-05-28 | NCT07469800 Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity |
Recruitment opened |
| 2026-05-27 | NCT07456839 A Mutiple-dose Study of IBI3033 in Healthy Participants |
overall status: "Not Yet Recruiting" → "Active Not Recruiting" |
| 2026-05-23 | NCT07311226 A First-in-human, Single-ascending-dose Study of IBI3033 in Healthy Participants |
overall status: "Not Yet Recruiting" → "Active Not Recruiting" |
| 2026-05-16 | NCT07502534 A Clinical Study Comparing the Bioequivalence of IBI3027 and DUPIXENT®(Dupilumab) in… |
overall status: "Not Yet Recruiting" → "Active Not Recruiting" |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-03 | NCT07622368 A Study of IBI3031 in Participants With Thyroid Eye Disease | Phase 1 | Not Yet Recruiting |
| 2026-06-03 | NCT07623798 A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003 | Phase 3 | Not Yet Recruiting |
| 2026-05-28 | NCT07612137 Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced… | Phase 1/2 | Not Yet Recruiting |
| 2026-05-15 | NCT07591519 Clinical Trials of IBI3035 in Healthy Subjects | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07255209 | A Study of IBI362 in Chinese Adolescents With Obesity or Overweight | Adolescents With Obesity or Overweight With Weight-Related Comorbidities | Recruiting |
| NCT07473960 | IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia | Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia | Recruiting |
| NCT07469800 | Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity | Overweight | Recruiting |
| NCT06884293 | A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With… | Overweight | Active, Not Recruiting |
| NCT06238843 | A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's… | Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Active, Not Recruiting |
| NCT05890742 | A Clinical Trial Evaluating the Efficacy and Safety of IBI310 in Combination With… | MSI-H | Active, Not Recruiting |
| NCT07623798 | A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003 | Relapsed or Refractory Multiple Myeloma | Not Yet Recruiting |
| Phase 2 | |||
| NCT07399067 | A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis | Atopic Dermatitis | Recruiting |
| NCT07330934 | A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe… | Atopic Dermatitis | Recruiting |
| NCT07483567 | IBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of… | CLDN18.2 Positive | Recruiting |
| NCT07483554 | IBI343 in Combination Therapy for Advanced Malignant Solid Tumors | CLDN18.2 Positive | Recruiting |
| NCT07352969 | A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients | Hypertension | Not Yet Recruiting |
| NCT07402070 | IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer | Resectable Stage II-III Non-small Cell Lung Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06974812 | IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors | Unresectable Locally Advanced or Metastatic Solid Tumors | Recruiting |
| NCT07612137 | Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced… | Solid Tumor | Not Yet Recruiting |
| Phase 1 | |||
| NCT07554222 | Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by… | Healthy | Recruiting |
| NCT05458219 | A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or… | Locally Advanced Unresectable or Metastatic Solid Tumors | Recruiting |
| NCT07559019 | Safety and Preliminary Activity of BI115 in Advanced SCLC | Small Cell Lung Cancer (SCLC) | Recruiting |
| NCT05290597 | A Phase 1, Open-label, Multicenter, Dose Escalation Study of IBI363 (PD1-IL2m) in… | Solid Malignancies or Lymphomas | Active, Not Recruiting |
| NCT07549984 | A Study of IBI3033 in Moderate-to-Severe Atopic Dermatitis | Atopic Dermatitis | Not Yet Recruiting |
| NCT07556796 | Study of IBI3016 in People With Mild or Moderate Hypertension Patients | Hypertension | Not Yet Recruiting |
| NCT07502534 | A Clinical Study Comparing the Bioequivalence of IBI3027 and DUPIXENT®(Dupilumab) in… | Healthy Volunteers | Active, Not Recruiting |
| NCT07591519 | Clinical Trials of IBI3035 in Healthy Subjects | Healthy Person | Not Yet Recruiting |
| NCT07311226 | A First-in-human, Single-ascending-dose Study of IBI3033 in Healthy Participants | Healthy Participants | Active, Not Recruiting |
| NCT07456839 | A Mutiple-dose Study of IBI3033 in Healthy Participants | Healthy Participants | Active, Not Recruiting |